Download the OCALIVA brochure so you can take a close look at the key information contained on this site. You can read it, print it, or send it to a friend, right from your desktop.
OCALIVA is a once-daily pill for adults who have PBC. It can be taken in combination with another medicine called ursodeoxycholic acid (UDCA). For people who cannot tolerate UDCA, OCALIVA can be taken alone.
Yes. OCALIVA may be taken in combination with ursodeoxycholic acid (UDCA) to help further lower alkaline phosphatase (ALP) levels.
Some medicines used to lower blood cholesterol levels, so-called bile acid resins (including cholestyramine, colestipol, and colesevelam) may reduce the effectiveness of OCALIVA. If you are taking a bile acid resin, take OCALIVA at least 4 hours before or 4 hours after taking the bile acid resin, or at as great an interval as possible. Certain drugs such as warfarin and CYP1A2 substrates (including theophylline and tizanidine) can interact with OCALIVA, so it is important to tell your healthcare provider about all the medicines you take.
You should not take OCALIVA if you have been diagnosed with complete biliary obstruction. Talk to your doctor to see if OCALIVA is right for you.
Take a look here to see how OCALIVA works. Your doctor can see if OCALIVA is working for you by tracking the results from your liver function tests. Work with your doctor to follow your progress and to make sure you are taking the dose of OCALIVA that works best to lower your alkaline phosphatase (ALP) level.
Your doctor will determine if OCALIVA is right for you. Once you have a prescription for OCALIVA, you will be contacted by a Care Coordinator from Interconnect® who will help you get started.
The Care Coordinators at Interconnect® can help you find out how much of the cost of OCALIVA is covered by your insurance or any applicable financial assistance programs.
Interconnect® is committed to providing access to OCALIVA to everyone who qualifies. You can reach out to an Interconnect Care Coordinator to get support for your prescription coverage.
Yes. OCALIVA is a prescription medicine and cannot be accessed without a prescription.
OCALIVA can be taken with or without food.
OCALIVA should be stored at 20ºC-25ºC (68ºF-77ºF); excursions permitted to 15ºC-30ºC (59ºF -86ºF).
Talk to your doctor if you miss a dose of OCALIVA.
Once prescribed OCALIVA, Interconnect® can help you get started.
Doctors use blood tests to check for different enzymes that act as markers of liver health. For people with PBC, very important liver markers include alkaline phosphatase and bilirubin.
Yes. Studies suggest that some people who are already taking ursodeoxycholic acid (UDCA) can add OCALIVA to their treatment to further lower their alkaline phosphatase (ALP) levels.
No. The severity of pruritus and fatigue are not related to how far the disease has progressed. In fact, for some people, pruritus gets better as their liver health gets worse. The best way to tell if OCALIVA is working for you is to track your alkaline phosphatase (ALP) level over time. Guidelines recommend that you see your doctor regularly to get your ALP level tested.
Be sure to tell your healthcare provider if pruritus develops or worsens during treatment with OCALIVA. These are not all the possible side effects associated with OCALIVA. Tell your healthcare provider if you experience any side effect that bothers you or does not go away.
Report to your healthcare provider immediately if you develop any symptoms of worsening liver disease. Be sure to tell your healthcare provider if pruritus develops or worsens during treatment with OCALIVA. These are not all the possible side effects associated with OCALIVA. Tell your healthcare provider if you experience any side effect that bothers you or does not go away. To report negative side effects of OCALIVA, please contact Intercept Pharmaceuticals, Inc. at 1-844-782-ICPT or you may report to FDA at www.fda.gov/medwatch or 1-800-FDA-1088.